The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.00
Bid: 39.40
Ask: 40.00
Change: -1.60 (-3.87%)
Spread: 0.60 (1.523%)
Open: 41.30
High: 41.30
Low: 39.55
Prev. Close: 41.30
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING: Zambeef sees profit above market views; Luceco trades in line

Tue, 07th Nov 2023 17:47

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Luceco PLC - London-based lighting manufacturer and distributor - Says that in the three months ended September 30, it traded in line with expectations. Revenue in the third quarter was 8.3% ahead of the prior year. Looking ahead, Luceco left its full-year guidance unchanged. Chief Executive Officer John Hornby says: "Whilst demand from energy saving professional projects continues its positive path; we are seeing some impact of reduced demand in certain of our end markets as the UK consumer continues to experience economic headwinds. Luceco's strong cash generation in the quarter was particularly encouraging, and with our low levels of net debt, the group is well placed to invest in growth and enhance earnings in line with strategic priorities."

----------

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Further expands partnership with M8 Pharmaceuticals Inc. Says M8 has taken up its rights to extend its licensing agreement from Brazil and Mexico to market MED3000 in a further fourteen countries throughout the Central and South American region. Futura has received an undisclosed upfront milestone payment from M8 as part of the extended agreement. The extension builds on the agreement signed in August 2021. Apart from the geographic expansion, the commercial terms and initial duration of the agreement remain unchanged. CEO James Barder says: "This is another major step forward in the execution of Futura's strategy. M8 is an excellent partner with dedicated brand-building and marketing experience, as well as scale and strong pharmaceutical connections in South and Central America and we look forward to working closely with them across the Latin American region."

----------

Vianet Group PLC - Stockton-on-Tees, England-based provider of retail sales and volume monitoring systems - Intends to conduct on-market purchases under a share buyback programme. The programme, which will be funded from its existing cash resources, is intended to reduce the share capital of the company. The buyback will begin immediately and will close at the conclusion of the 2024 annual general meeting, or September 5.

----------

Scotgold Resources Ltd - Stirlingshire, Scotland-based gold and silver exploration company's- Says it is considering the appointment of administrators "over the coming days." In October, Scotgold said it was in "advanced" financing discussions with a strategic investor, but now says the discussions "have not resulted in an investment at this time." Its share were suspended in September, pending clarification of its financial position.

----------

Zambeef Products PLC - Lusaka-based cold chain foods and retail business with operations in Zambia, Nigeria and Ghana - Says forward guidance on financial trading performance for the year ended September 30 is expected to be above market expectations, despite a challenging operating environment. Says revenue, gross profit and adjusted earnings before interest, tax, depreciation and amortisation are expected to be between 5-15% higher than market expectations. Reported pretax profit is expected to be about 30% higher than current market expectations. "The group continued to see increasing demand for its products, supported by a price moderation approach, resulting in volume growth across most product categories. Lower than expected selling prices and higher input costs (which couldn't fully be passed on to the consumer), including fuel and electricity, put pressure on gross margins which moderated in the second half," it says.

----------

F&C Investment Trust PLC - aims for long-term growth and income by investing in listed equities globally - Says that a third dividend for 2023 will be paid. Ups quarterly dividend to 3.40p from 3.20p a year earlier. Looking ahead, F&C plans to deliver another rise in our total dividend for this year, which will be the 53rd consecutive annual rise.

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
4 May 2016 08:26

Futura Medical Completes Recruitment For Erectile Dysfunction Study

Read more
15 Mar 2016 10:30

Futura Says Research Costs To Fall After Ramping Up Spending In 2015

Read more
7 Mar 2016 09:08

Futura Medical Appoints Former Glaxo Executive As Non-Executive

Read more
16 Dec 2015 08:27

Futura Medical Achieves Extended Shelf Life For Condom

Read more
24 Nov 2015 11:01

Futura Medical Gets Positive Regulatory Advice On Pain Relief Products

Read more
17 Nov 2015 10:56

Futura Medical Says MED2002 Trial Recruitment Proceeding Well

Read more
23 Oct 2015 06:52

Futura Medical Gets Confirmation Of NHS Reimbursement For MED2002

Read more
14 Oct 2015 08:12

Futura Medical, Quantum Pharma Agree Erectile Dysfunction Drug Deal

Read more
9 Sep 2015 08:29

Futura Medical Loss Widens As It Moves Toward Product Rollouts

Read more
14 Jul 2015 09:01

Futura Medical Says Two Pain Relief Products Meet Endpoints, One Fails

Read more
25 Jun 2015 08:13

Futura Medical Gets All Approvals For MED2002 Efficacy Trial

Read more
17 Jun 2015 11:12

Futura Medical says product portfolio is in line with business plan

Futura Medical, a healthcare company focused on transdermal technology, said on Wednesday its product portfolio has been progressing in line with expectations. Ahead of its annual general meeting, the group said it is working on a modified manufacturing process on its CSD500 condom to extend the pro

Read more
17 Jun 2015 09:16

Futura Medical Says Product Portfolio Progressing In Line With Plans

Read more
17 Jun 2015 07:24

LONDON MORNING BRIEFING: Shares Gain Ahead Of Bank Of England And Fed

Read more
17 Jun 2015 05:23

AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.